All Stories

  1. Roles, workforce patterns, and concerns of psychologists working in New Zealand public hospitals: Findings from a national mixed-methods survey
  2. Beyond beds and band‐aids: A call for improved services across the whole dementia journey
  3. Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures
  4. What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial
  5. Scopolamine's Anticholinergic Effects on EEG Spectral, Aperiodic, Complexity, Microstates, and Heart Rate Variability
  6. A qualitative exploration of community pharmacist views on providing a mental health and well-being intervention for long-term condition patients
  7. Mapping Neuroinflammation With Diffusion-Weighted Magnetic Resonance Imaging: A Randomized Crossover Study
  8. A qualitative study of community pharmacists in New Zealand: mental health literacy and the barriers and facilitators to providing and receiving mental healthcare in community pharmacies
  9. Early experiences of the End of Life Choice Act 2019 amongst assisted dying practitioners in Aotearoa New Zealand
  10. Rethinking measurement: a preliminary study of mental health literacy among college students
  11. Practitioners’ attitudes and approaches to assessing comorbid depression among patients seeking assisted dying in New Zealand
  12. The Cost-Effectiveness of Mindfulness-Based Interventions for Medical Students: A Scoping Review
  13. The Identification and Management of Subthreshold Depression and Anxiety in Primary Care for People With Long‐Term Conditions
  14. The Effects of Neuroinflammation Induced by Typhoid Vaccine on Resting and Task‐Based Electroencephalography
  15. Understanding the scope of Consultation-Liaison Psychiatry referrals in a general hospital setting in New Zealand
  16. Advancing health coaching: A comparative study of large language model and health coaches
  17. A survey of the psychiatric care provided for children and young people in general hospital settings in New Zealand
  18. Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
  19. LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
  20. Transforming a Psychiatry Curriculum: Narrative Review of Essential Elements
  21. Nitrous oxide myelopathy: a case series
  22. LSD increases sleep duration the night after microdosing
  23. Mindfulness and Religiosity: Four Propositions to Advance a More Integrative Pedagogical Approach
  24. PAM trial protocol: a randomised feasibility study of psychedelic microdosing–assisted meaning-centred psychotherapy in advanced stage cancer patients
  25. Towards Personalised Mood Prediction and Explanation for Depression from Biophysical Data
  26. Pacific Cultural Enhancement of Mindfulness-Based Cognitive Therapy: Insights from Clinical and Cultural Experts
  27. An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
  28. Perspectives from gambling expert stakeholders in relation to electronic gaming machines in New Zealand
  29. Broadening the state of play – the second national survey of Consultation-Liaison Psychiatry services in New Zealand, 2021
  30. From the chemical imbalance to the power imbalance: A psychiatry trainee’s perspectives on service-user supervision
  31. Detection of Neuroinflammation Induced by Typhoid Vaccine Using Quantitative Magnetization Transfer MR: A Randomized Crossover Study
  32. A survey of the psychiatric care provided for medically ill older adults in general hospitals in New Zealand
  33. Towards Personalised Depression Modelling and Explanation from Wearable Data
  34. Towards integrated Consultation-Liaison Psychiatry for older adults in New Zealand
  35. Cultural Factors in Behavioral Health Assessment
  36. The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey
  37. A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder
  38. A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder
  39. A national study of the mental health literacy of community pharmacists
  40. Mindfulness-Based Cognitive Therapy for Stress Reduction in Family Carers of People Living with Dementia: A Systematic Review
  41. Brain temperature as an indicator of neuroinflammation induced by typhoid vaccine: Assessment using whole-brain magnetic resonance spectroscopy in a randomised crossover study
  42. Using Acoustic Speech Patterns From Smartphones to Investigate Mood Disorders: Scoping Review
  43. Depression and suicidal ideation among dental students of Southern Saudi Arabia: A cross sectional study
  44. Cancer Healthcare Workers’ Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation
  45. Concurrent Disorders and Decision-Making in Electronic Gaming Machine Gamblers
  46. FACT effectiveness in primary care; a single visit RCT for depressive symptoms
  47. MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
  48. A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties
  49. Using Acoustic Speech Patterns From Smartphones to Investigate Mood Disorders: Scoping Review (Preprint)
  50. Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors
  51. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder
  52. The state of play – the first national survey of consultation-liaison psychiatry services in New Zealand
  53. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4–6 μg/kg) in patients with major depressive disorder
  54. Ketamine Enhances Visual Sensory Evoked Potential Long-term Potentiation in Patients With Major Depressive Disorder
  55. Disrupted white matter integrity in treatment-resistant schizophrenia
  56. A proof-of-principle study of the short-term effects of MDMA (3,4-methylenedioxymethamphetamine) on tinnitus and neural connectivity.
  57. Nonepileptic seizures in individuals attending neurological services in New Zealand
  58. The multi-dimensional matrix for consultation-liaison psychiatry (mMAX-LP)
  59. Impact of Using a 3D Visual Metaphor Serious Game to Teach History-Taking Content to Medical Students: Longitudinal Mixed Methods Pilot Study
  60. Imaging
  61. Evaluating Commonalities Across Medically Unexplained Symptoms
  62. Impact of Using a 3D Visual Metaphor Serious Game to Teach History-Taking Content to Medical Students: Longitudinal Mixed Methods Pilot Study (Preprint)
  63. Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia
  64. Neural plasticity is modified over the human menstrual cycle: Combined insight from sensory evoked potential LTP and repetition suppression
  65. Motivations, Expectations and Experiences in Being a Mental Health Helplines Volunteer
  66. Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia
  67. Peak visual gamma frequency is modified across the healthy menstrual cycle
  68. Do suicide characteristics differ by age in older people?
  69. Late-Life Suicide in Terminal Cancer: A Rational Act or Underdiagnosed Depression?
  70. The Impact of Self-Esteem, Academic Self-Efficacy and Perceived Stress on Academic Performance: A Cross-Sectional Study of Saudi Psychology Students
  71. Predictors for repeat self-harm and suicide among older people within 12 months of a self-harm presentation
  72. Social anxiety apps: a systematic review and assessment of app descriptors across mobile store platforms
  73. Tips and Traps: Lessons From Codesigning a Clinician E-Monitoring Tool for Computerized Cognitive Behavioral Therapy
  74. Optimization of High Definition Transcranial Direct Current Stimulation (HDtDCS) For Tinnitus Relief
  75. A brief treatment for fear of heights
  76. The resource utilisation of medically unexplained physical symptoms
  77. Death wishes among older people assessed for home support and long-term aged residential care
  78. Who Are the Elderly Who Want to End Their Lives?
  79. Elderly disempowerment and do the means justify the end?
  80. Understanding the Progression from Physical Illness to Suicidal Behavior: A Case Study Based on a Newly Developed Conceptual Model
  81. Enhancing suicide risk assessment: a novel visual metaphor learning tool
  82. Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy
  83. The resource utilisation associated with medically unexplained physical symptoms
  84. Late-life suicide: Insight on motives and contributors derived from suicide notes
  85. Intensity, Duration, and Location of High-Definition Transcranial Direct Current Stimulation for Tinnitus Relief
  86. Visualizing psychiatric formulation
  87. Medical examiner and coroner reports: uses and limitations in the epidemiology and prevention of late-life suicide
  88. Late-life homicide-suicide: a national case series in New Zealand
  89. Non-graduate and graduate entry medical students attitudes to psychiatry
  90. White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder
  91. Practical Guidelines for Managing Patients with 22q11.2 Deletion Syndrome
  92. Electroconvulsive Therapy Training and Confidence in Administration
  93. White matter integrity in Asperger syndrome: A preliminary diffusion tensor magnetic resonance imaging study in adults
  94. Schizophrenia and 22q11.2 Deletion Syndrome
  95. Neuroanatomical correlates of psychosis in temporal lobe epilepsy: voxel-based morphometry study
  96. White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults
  97. White matter microstructure in 22q11 deletion syndrome: a pilot diffusion tensor imaging and voxel-based morphometry study of children and adolescents
  98. Is there an increased prevalence of autistic spectrum disorders in people with 22q11 Deletion Syndrome?
  99. White matter microstructure in children with Velocardiofacial Syndrome: A Diffusion Tensor Imaging and Voxel Based Morphometry study
  100. Neuropsychiatry of epilepsy
  101. Risk factors for violence: an audit on the effect of a tutorial on risk assessment
  102. Velo-Cardio-Facial Syndrome/22q11 Deletion Syndrome